comparemela.com

Klaus Breiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Strong investment continues for developer of Autoimmune Therapies

Biotech start-up Tridek-One focused on research and development of CD31 agonists to restore the immune balance, has closed a €16 million ($16. Click to read more.

Tridek-One Closes €16M Funding

Tridek-One Closes €16M Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Tridek-One bags €16M to develop auto-immune diseases candidates

Tridek-One SAS, which specializes in the R&D of CD31 agonists to restore immune balance, has closed a €16 million financing round.

Pureos BioVentures pulls in $205m to close debut drug developer-focused fund

7 Pureos Bioventures has hit a $205m final close for its debut fund, which will look to back developers of novel biologica Sorry, you need to subscribe to read this article. If you would like to access this article you must become a Premium Subscriber. Premium subscribers receive complete access to our daily breaking news, premium stories, weekly Fundraising & IR Review, Knowledge Bank and LP profiles - all which are accessible via our mobile platform.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.